(1) This section applies to a brand of a pharmaceutical item on a 26.1% price reduction day if:
(a) the 26.1% price reduction day is on or after the 15th anniversary of the drug in the pharmaceutical item being a listed drug; and
(b) the approved ex - manufacturer price of the brand of the pharmaceutical item has not been previously reduced under subsection 99ACF(1) or (2) because of:
(i) item 4 in the table in section 99ACF; or
(ii) item 4A in the table in section 99ACF; or
(iii) item 6 in the table in section 99ACF; or
(iv) item 8 in the table in section 99ACF; and
(c) the approved ex - manufacturer price of the brand of the pharmaceutical item has not been reduced on or before the 26.1% price reduction day:
(i) because of section 99ACB or 99ACD; or
(ii) because of repealed section 99ACE or repealed section 99ACH; or
(iii) under section 99ACQ; or
(iv) under subsection 99ACR(3); and
(d) subsection 99ACR(4) has not applied to the brand of the pharmaceutical item on or before the 26.1% price reduction day; and
(e) the pharmaceutical item is not an exempt item.
Note: See also section 99ACG.
(2) In this section, each of the following is a 26.1% price reduction day :
(a) 1 April 2023;
(b) 1 April 2024;
(c) 1 April 2025;
(d) 1 April 2026.